Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
CAS Number: 356559-13-2
Development of a comprehensive set of P2 receptor pharmacological research compounds
CYP17 inhibition is a new strategy to prevent androgen synthesis and treat lethal metastatic prostate cancer
H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14
also known as XRP0673
SKI-178 Size:10mg solid CAS Number: 356559-13-2SKI 178 is a potent sphingosine kinase 1 (SphK1) and SphK2 inhibitor. SKI 178 is cytotoxic at IC50 concentrations ranging from 1. 8 to 0. 1 M in both drug sensitive and multi drug resistant cancer cell lines (i. e., MTR3, NCI ADR and HL60 VCR cells). SKI 178 induces apoptosis in a CDK1 dependent manner in human acute myeloid leukemia cell lines. Product information CAS Number: 1259484 97 3 Molecular Weight: 394. 42 Formula: C21H22N4O4 Chemical Name:
US$ 30.00
US$ 28.00
US$ 45.00
US$ 125.00
US$ 72.00
US$ 14.00
US$ 34.00
US$ 40.00
US$ 86.00